Amit Hazan
Stock Analyst at Goldman Sachs
(2.16)
# 2,667
Out of 4,784 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $157.24 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $9.03 | -72.31% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.32 | +1,339.39% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.77 | -32.03% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $39.13 | +61.00% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $227.50 | +19.56% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $14.13 | +20.31% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $12.58 | +3,357.87% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $60.05 | -26.73% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $70.91 | +2.95% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $33.75 | +57.04% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $37.76 | +50.95% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $10.19 | -6.77% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $130.82 | -20.50% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $9.16 | +555.02% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $87.63 | +31.23% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $364.50 | -58.85% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $99.36 | -53.70% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $491.84 | -50.86% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $112.26 | +57.67% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $163.71 | -10.21% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.82 | +114.29% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $157.24
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $9.03
Upside: -72.31%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.32
Upside: +1,339.39%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.77
Upside: -32.03%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $39.13
Upside: +61.00%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $227.50
Upside: +19.56%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $14.13
Upside: +20.31%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $12.58
Upside: +3,357.87%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $60.05
Upside: -26.73%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $70.91
Upside: +2.95%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $33.75
Upside: +57.04%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $37.76
Upside: +50.95%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $10.19
Upside: -6.77%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $130.82
Upside: -20.50%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $9.16
Upside: +555.02%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $87.63
Upside: +31.23%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $364.50
Upside: -58.85%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $99.36
Upside: -53.70%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $491.84
Upside: -50.86%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $112.26
Upside: +57.67%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $163.71
Upside: -10.21%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.82
Upside: +114.29%